Classification of lung adenocarcinoma and squamous cell carcinoma samples based on their gene expression profile in the sbv IMPROVER Diagnostic Signature Challenge

Systems Biomedicine

Volumn 1, Issue 4, 2014, Pages 268-277

  Ben Hamo, Rotem ^a   Boue, Stephanie ^b   Martin, Florian ^b   Talikka, Marja ^b   Efroni, Sol ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Adenocarcinoma; Classification; Improver; Lung cancer; Squamous cell carcinoma

Indexed keywords

ANTHRAX TOXIN; COLLAGEN TYPE 1; CYTOKERATIN 14; DIPEPTIDYL PEPTIDASE IV; GLUTAMINYL EPTIDE CYCLOTRANSFERASE; MELANOMA ANTIGEN 4; PROTEIN; SECRETORY COMPONENT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; THROMBOSPONDIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; DISEASE COURSE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; SQUAMOUS CELL LUNG CARCINOMA;

EID: 84988917839     PISSN: 21628130     EISSN: 21628149     Source Type: Journal    
DOI: 10.4161/sysb.25983     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073
3. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J, Deschamps C. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005; 128:452-62; PMID:16002972; http://dx.doi.org/10.1378/chest.128.1.452
4. Pankratz VS, Sun Z, Aakre J, Li Y, Johnson C, Garces YI, Aubry MC, Molina JR, Wigle DA, Yang P. Systematic evaluation of genetic variants in three biological pathways on patient survival in lowstage non-small cell lung cancer. J Thorac Oncol 2011; 6:1488-95; PMID:21792076; http://dx.doi.org/10.1097/JTO.0b013e318223bf05
5. Brambilla E, Gazdar A. Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J 2009; 33:1485-97; PMID:19483050; http://dx.doi.org/10.1183/09031936.00014009
6. Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 2010; 28:5311-20; PMID:21079145; http://dx.doi.org/10.1200/JCO.2010.28.8126
7. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 2008; 3:1468-81; PMID:19057275; http://dx.doi.org/10.1097/JTO.0b013e318189f551
8. Inamura K, Fujiwara T, Hoshida Y, Isagawa T, Jones MH, Virtanen C, Shimane M, Satoh Y, Okumura S, Nakagawa K, et al. Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization. Oncogene 2005; 24:7105-13; PMID:16007138; http://dx.doi.org/10.1038/sj.onc.1208858
9. Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H, et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009; 63:32-8; PMID:18486272; http://dx.doi.org/10.1016/j.lungcan.2008.03.033
10. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, Fárez- Vidal ME. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer 2011; 129:355-64; PMID:20878980; http://dx.doi.org/10.1002/ijc.25704
11. Chang HH, Dreyfuss JM, Ramoni MF. A transcriptional network signature characterizes lung cancer subtypes. Cancer 2011; 117:353-60; PMID:20839314; http://dx.doi.org/10.1002/cncr.25592
12. Daraselia N, Wang Y, Budoff A, Lituev A, Potapova O, Vansant G, Monforte J, Mazo I, Ossovskaya VS. Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers. Am J Cancer Res 2012; 2:93-103; PMID:22206048
13. Meyer P, Alexopoulos LG, Bonk T, Califano A, Cho CR, De la Fuente A, de Graaf D, Hartemink AJ, Hoeng J, Ivanov NV, et al. Verification of systems biology research in the age of collaborative competition. Nat Biotechnol 2011; 29:811-5; PMID:21904331; http://dx.doi.org/10.1038/nbt.1968
14. Vapnik VN. Statistical Learning Theory. Wiley-Interscience, 1998.
15. Chapelle O, Schoelkopf B, Zien A. Discussion of Semi-Supervised Learning and Transduction. Semi-Supervised Learning: MIT press, 2006.
16. Gammerman A, Vovk V, Vapnik V. Learning by Transduction. http://www1cscolumbiaedu/~dplewis/candidacy/gammerman98learningpdf, 1998.
17. Reynolds A, Richards G, de la Iglesia B, Rayward-Smith V. Clustering rules: A comparison of partitioning and hierarchical clustering algorithms. J Math Model Algorithms 1992; 5:475-504; http://dx.doi.org/10.1007/s10852-005-9022-1
18. Sethi S, Geng L, Shidham VB, Archuletta P, Bandyophadhyay S, Feng J, Madan S, Shi D, Tranchida P, Giorgadze T. Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens. Cytojournal 2012; 9:10; PMID:22582081; http://dx.doi.org/10.4103/1742-6413.94570
19. Tian S, Suárez-Fariñas M. Hierarchical-TGDR: Combining biological hierarchy with a regularization method for multi-class classification of lung cancer samples via high-throughput gene-expression data. Systems Biomedicine 2013; e25979
20. Wang L, Liu T, Wang Y, Cao L, Nishioka M, Aguirre RL, Ishikawa A, Geng L, Okada N. Altered expression of desmocollin 3, desmoglein 3, and ß-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 2007; 451:959-66; PMID:17846785; http://dx.doi.org/10.1007/s00428-007-0485-5
21. Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, et al. Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol 2007; 38:276-83; PMID:17084439; http://dx.doi.org/10.1016/j.humpath.2006.08.006
22. Chidgey M, Dawson C. Desmosomes: a role in cancer? Br J Cancer 2007; 96:1783-7; PMID:17519903; http://dx.doi.org/10.1038/sj.bjc.6603808
23. Xie Y, Xiao G, Coombes KR, Behrens C, Solis LM, Raso G, Girard L, Erickson HS, Roth J, Heymach JV, et al. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients. Clin Cancer Res 2011; 17:5705-14; PMID:21742808; http://dx.doi.org/10.1158/1078-0432.CCR-11-0196
24. Starczynowski DT, Lockwood WW, Deléhouzée S, Chari R, Wegrzyn J, Fuller M, Tsao MS, Lam S, Gazdar AF, Lam WL, et al. TRAF6 is an amplified oncogene bridging the RAS and NF-?B pathways in human lung cancer. J Clin Invest 2011; 121:4095-105; PMID:21911935; http://dx.doi.org/10.1172/JCI58818
25. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-93; PMID:12538238; http://dx.doi.org/10.1093/bioinformatics/19.2.185